SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form D - Notice of Exempt Offering of Securities:
SEC Accession No. 0001851933-21-000001
Filing Date
2021-03-18
Accepted
2021-03-18 10:57:42
Documents
1
Effectiveness Date
2021-03-18
Items
Item 06b:

Document Format Files

Seq Description Document Type Size
1 primary_doc.html D  
1 primary_doc.xml D 5938
  Complete submission text file 0001851933-21-000001.txt   7032
Mailing Address 535 W. RESEARCH CENTER BLVD. SUITE 135 FAYETTEVILLE AR 72701
Business Address 535 W. RESEARCH CENTER BLVD. SUITE 135 FAYETTEVILLE AR 72701 4795212592
VIN-24 Neurexis Therapeutics, LLC (Filer) CIK: 0001851933 (see all company filings)

IRS No.: 862041070 | State of Incorp.: AR | Fiscal Year End: 1231
Type: D | Act: 33 | File No.: 021-392691 | Film No.: 21753494